{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:33:22Z","timestamp":1775183602724,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T00:00:00Z","timestamp":1450828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Merck Sharp & Dohme China."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s13277-015-4441-8","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T15:49:35Z","timestamp":1450885775000},"page":"7893-7900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China"],"prefix":"10.1007","volume":"37","author":[{"given":"Junru","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuogang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daobin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"issue":"8","key":"4441_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1086\/605664","volume":"49","author":"M Nucci","year":"2009","unstructured":"Nucci M, Anaissie E. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis. 2009;49(8):1211\u201325. doi: 10.1086\/605664 .","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4441_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/bmt.2008.303","volume":"43","author":"L Gil","year":"2009","unstructured":"Gil L, Kozlowska-Skrzypczak M, Mol A, Poplawski D, Styczynski J, Komarnicki M. Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. Bone Marrow Transplant. 2009;43(2):121\u20136. doi: 10.1038\/bmt.2008.303 .","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"4441_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/myc.12161","volume":"57","author":"A Candoni","year":"2014","unstructured":"Candoni A, Caira M, Cesaro S, Busca A, Giacchino M, Fanci R, et al. Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study. Mycoses. 2014;57(6):342\u201350. doi: 10.1111\/myc.12161 .","journal-title":"Mycoses"},{"issue":"8","key":"4441_CR4","first-page":"1068","volume":"91","author":"L Pagano","year":"2006","unstructured":"Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91(8):1068\u201375.","journal-title":"Haematologica"},{"issue":"6","key":"4441_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12185-012-1210-y","volume":"96","author":"M Kurosawa","year":"2012","unstructured":"Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M, et al. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol. 2012;96(6):748\u201357. doi: 10.1007\/s12185-012-1210-y .","journal-title":"Int J Hematol"},{"issue":"12","key":"4441_CR6","first-page":"1026","volume":"48","author":"BH Huang","year":"2009","unstructured":"Huang BH, Li J, Liu JR, Gu JL. The clinical features and risk factors for invasive fungal infection in multiple myeloma. Zhonghua Nei Ke Za Zhi. 2009;48(12):1026\u201330.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"4441_CR7","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.3324\/haematol.2014.114025","volume":"100","author":"BW Teh","year":"2015","unstructured":"Teh BW, Teng JC, Urbancic K, Grigg A, Harrison SJ, Worth LJ, et al. Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies. Haematologica. 2015;100(1):e28\u201331. doi: 10.3324\/haematol.2014.114025 .","journal-title":"Haematologica"},{"issue":"2","key":"4441_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s13277-014-2649-7","volume":"36","author":"Y Sun","year":"2015","unstructured":"Sun Y, Huang H, Chen J, Li J, Ma J, Li J, et al. Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China. Tumour Biol. 2015;36(2):757\u201367. doi: 10.1007\/s13277-014-2649-7 .","journal-title":"Tumour Biol"},{"issue":"5","key":"4441_CR9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121(5):749\u201357.","journal-title":"Br J Haematol"},{"issue":"12","key":"4441_CR10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813\u201321. doi: 10.1086\/588660 .","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4441_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34(1):7\u201314. doi: 10.1086\/323335 .","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4441_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3109\/13693786.2011.630040","volume":"50","author":"DA Tsitsikas","year":"2012","unstructured":"Tsitsikas DA, Morin A, Araf S, Murtagh B, Johnson G, Vinnicombe S, et al. Impact of the revised (2008) EORTC\/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis. Med Mycol. 2012;50(5):538\u201342. doi: 10.3109\/13693786.2011.630040 .","journal-title":"Med Mycol"},{"issue":"11","key":"4441_CR13","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/jac\/dks266","volume":"67","author":"R Herbrecht","year":"2012","unstructured":"Herbrecht R, Caillot D, Cordonnier C, Auvrignon A, Thiebaut A, Brethon B, et al. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. J Antimicrob Chemother. 2012;67(11):2731\u20138. doi: 10.1093\/jac\/dks266 .","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"4441_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3324\/haematol.2012.061952","volume":"97","author":"JA Maertens","year":"2012","unstructured":"Maertens JA, Nucci M, Donnelly JP. The role of antifungal treatment in hematology. Haematologica. 2012;97(3):325\u20137. doi: 10.3324\/haematol.2012.061952 .","journal-title":"Haematologica"},{"issue":"3","key":"4441_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1086\/649879","volume":"50","author":"K Leventakos","year":"2010","unstructured":"Leventakos K, Lewis RE, Kontoyiannis DP. Fungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis. 2010;50(3):405\u201315. doi: 10.1086\/649879 .","journal-title":"Clin Infect Dis"},{"issue":"36","key":"4441_CR16","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1200\/jco.2005.03.2086","volume":"23","author":"BM Augustson","year":"2005","unstructured":"Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002\u2014Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005;23(36):9219\u201326. doi: 10.1200\/jco.2005.03.2086 .","journal-title":"J Clin Oncol"},{"issue":"1","key":"4441_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","volume":"43","author":"KW Garey","year":"2006","unstructured":"Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006;43(1):25\u201331.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"4441_CR18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3324\/haematol.2011.042598","volume":"96","author":"L Pagano","year":"2011","unstructured":"Pagano L, Caira M, Nosari A, Cattaneo C, Fanci R, Bonini A, et al. HEMA e-Chart Group. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project. Haematologica. 2011;96(9):1366\u201370. doi: 10.3324\/haematol.2011.042598 .","journal-title":"Haematologica"},{"issue":"4","key":"4441_CR19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356(4):348\u201359.","journal-title":"N Engl J Med"},{"issue":"4","key":"4441_CR20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med. 2007;356(4):335\u201347.","journal-title":"N Engl J Med"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4441-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4441-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4441-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4441-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:43:45Z","timestamp":1559490225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4441-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["4441"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4441-8","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}